Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2017 Aug 25;190(2):226–234. doi: 10.1111/cei.13012

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2017 The Authors. Clinical and Experimental Immunology published by John Wiley & Sons Ltd on behalf of British Society for Immunology

This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.

PMC Copyright notice

Percentage of primary immunodeficiency (PID) patients receiving prophylactic antibiotics, rituximab, steroids and other treatments, (a) without lung disease, (b) with bronchiectasis, and (c) with ‘other lung disease’. : Adult patients : Paediatric patients.

Inline graphic — Percentage of primary immunodeficiency (PID) patients receiving prophylactic antibiotics, rituximab, steroids and other treatments, (a) without lung disease, (b) with bronchiectasis, and (c) with ‘other lung disease’. : Adult patients : Paediatric patients.